Author Archives: Gemma Telfer

DiMe Digital Medicine Society

AARDEX Group Partners with Industry Leaders on DiMe’s Digital Medicine Society’s V3+ Framework Project to Enhance Usability of DHTs

Extending the Verification, Analytical Validation and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences. Liege, Belgium- May 3, 2023: Adherence specialists AARDEX Group is proud to announce its partnership with other industry leaders … Read More

Outsourcing in Clinical Trials Europe (1)

Meet us at Outsourcing in Clinical Trials Europe 2023

Exciting news! AARDEX Group is gearing up for one of the most highly anticipated events in the clinical trials industry – the 13th Annual Outsourcing in Clinical Trials Europe conference, which will take place in the beautiful city of Barcelona … Read More

Pill Count Compliance It's Time to Burst the Drug Trial Bubble

Pill Count Compliance: It’s Time to Burst the Drug Trial Bubble

In this article, our Scientific Lead and Adherence Expert, Bernard Vrijens, explores the use of pill count compliance in clinical trials and its reliability for measuring medication adherence. Pressure is ubiquitous when it comes to conducting clinical trials. Sponsors feel the … Read More

Job van Boven

Job van Boven: A View from a Career-Long Journey into Medication Adherence

Dr. Job van Boven, Associate Professor at the University Medical Center Groningen, shares his invaluable insights on the evolution of medication adherence monitoring solutions.  According to Dr. Job van Boven, Associate Professor at the University Medical Center Groningen, Founding Director of … Read More

Chief Medical Officer Summit: Take on the CMO Step-Up Challenge to Win a Meta Quest VR Headset!

About the CMO Step-Up Challenge What is the #CMOStepUp Challenge all about, you may ask? It’s a step challenge where participants will compete to clock the most steps and emerge victorious with the Meta Quest VR Headset as their reward. … Read More

March 2023 Medication Monitoring Matters Newsletter

Greetings and salutations! It’s time for the March issue of the Medication Monitoring Matters newsletter, where we delve into cutting-edge advancements in medication adherence monitoring. In this edition, we’ll examine the potential downsides of Video Directly Observed Therapy (VDOT) as … Read More

Ask the Adherence Experts Edition Two: Ken Getz

In clinical trial analysis, it’s assumed that participants are following the instructions for the investigational product. Unfortunately, the evidence suggests that this is far from reality. Recently, Kenneth Getz, Executive Director and Professor at the Tufts Center for the Study … Read More

Medication Monitoring Matters Newsletter: February 2023 Edition

Greetings from the forefront of innovation in clinical trials. We’re thrilled to introduce you to the first edition of our medication adherence newsletter, Medication Monitoring Matters. Our focus? Empowering clinical trial sponsors like you to elevate the standard of care … Read More

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials

Seamless integration of adherence and research data protects participant safety and data quality, with no additional burden for clinical trial sites or participants Liege, Belgium- February 2, 2023: Adherence specialists AARDEX Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up … Read More

Ask the Medication Adherence Experts: Edition One

Poor medication adherence during clinical trials can skew results, leading to underestimations of product efficacy, inaccurate pharmacokinetic/pharmacodynamic calculations, and even put participant safety at risk.1 Research has shown that up to 50% of people who take part in drug development … Read More